Arkolith/Insider Trading/OTLK

OTLK Insider Trading

Outlook Therapeutics, Inc. · full profile →Last filing Sep 1, 2026

Outlook Therapeutics, Inc. also files under ONS; those filings are included.

Net Buying · 180d
Open-Market Buys (180d)
$7.9M
7 insiders
Open-Market Sells (180d)
$0
0 insiders
Net Insider Flow
$7.9M
open market, 180d
Reporting Insiders
7
10 P/S transactions
Build

Build on these Form 4 transactions

The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.

Form 4 insider API

Open-market buys and sells, cluster scans, company flows.

insider.transactions

13F holdings API

Owners, holdings, deltas, point-in-time portfolios.

stock.owners

MCP quickstart

Connect an agent, mint a key, make the first call.

/api/mcp

Recent Form 4 Transactions

100 shown
DateInsiderRoleActionSharesPriceValue
Sep 1, 2026Lundquist Kevin MichaelChief Financial OfficerGrant(A)500K—$0
Aug 14, 2026Kenyon Lawrence AChief Financial Officer, DirectorBuy(P)101K——
Aug 14, 2026Kenyon Lawrence AChief Financial Officer, DirectorBuy(P)101K——
Aug 14, 2026Jahr Robert CharlesChief Executive Officer, DirectorBuy(P)152K——
Aug 14, 2026Jahr Robert CharlesChief Executive Officer, DirectorBuy(P)152K——
Aug 12, 2026Sukhtian Ghiath M.Director, 10% OwnerBuy(P)2.5M—$0
Aug 12, 2026Sukhtian Ghiath M.Director, 10% OwnerBuy(P)2.5M$0.99$2.5M
Jul 29, 2026Sukhtian Faisal GhiathDirectorBuy(P)95K$1.05$100K
Jul 21, 2026Kenyon Lawrence AChief Financial Officer, DirectorGrant(A)210K—$0
Jul 21, 2026Jahr Robert CharlesChief Executive Officer, DirectorGrant(A)100K—$0
Jun 2, 2026Haddadin Yezan MuntherDirectorBuy(P)29K$0.83$24K
May 28, 2026Sukhtian Ghiath M.Director, 10% OwnerBuy(P)8.5M$0.59$5.0M
May 28, 2026Sukhtian Ghiath M.Director, 10% OwnerBuy(P)8.6M——
May 28, 2026Sukhtian Ghiath M.Director, 10% OwnerBuy(P)3.5M——
May 28, 2026Sukhtian Ghiath M.Director, 10% OwnerExpiration(H)8.6M——
May 28, 2026Sukhtian Ghiath M.Director, 10% OwnerExpiration(H)3.5M——
May 28, 2026Sukhtian Ghiath M.Director, 10% OwnerBuy(P)3.5M——
May 28, 2026Sukhtian Ghiath M.Director, 10% OwnerExpiration(H)3.5M——
May 27, 2026Sukhtian Faisal GhiathDirectorBuy(P)122K$0.41$50K
May 26, 2026Thurman Randy HDirectorBuy(P)5K$0.43$2K
May 26, 2026Hilzinger Kurt JDirectorBuy(P)400K$0.44$177K
May 26, 2026Haddadin Yezan MuntherDirectorBuy(P)34K$0.44$15K
Oct 3, 2025Huang AndongDirectorGrant(A)53K—$0
Oct 3, 2025Sukhtian Faisal GhiathDirectorGrant(A)117K—$0
Oct 3, 2025Haller Julia ADirectorGrant(A)59K—$0
Oct 3, 2025Auffarth GerdDirectorGrant(A)59K—$0
Oct 3, 2025Hilzinger Kurt JDirectorGrant(A)91K—$0
Oct 3, 2025Haddadin Yezan MuntherDirectorGrant(A)96K—$0
Oct 1, 2025Huang AndongDirectorGrant(A)287K—$0
Oct 1, 2025Haller Julia ADirectorGrant(A)287K—$0
Oct 1, 2025Haddadin Yezan MuntherDirectorGrant(A)287K—$0
Oct 1, 2025Hilzinger Kurt JDirectorGrant(A)287K—$0
Oct 1, 2025Auffarth GerdDirectorGrant(A)287K—$0
Oct 1, 2025Sukhtian Faisal GhiathDirectorGrant(A)287K—$0
Oct 1, 2025Gangolli Julian SDirectorGrant(A)287K—$0
Oct 1, 2025Thurman Randy HDirectorGrant(A)287K—$0
Jul 1, 2025Jahr Robert CharlesChief Executive OfficerGrant(A)800K—$0
May 27, 2025Sukhtian Ghiath M.Director, 10% OwnerGrant(A)4.3M$1.40$6.0M
May 27, 2025Sukhtian Ghiath M.Director, 10% OwnerGrant(A)8.6M——
Feb 4, 2025Sukhtian Faisal GhiathDirectorGrant(A)12K—$0
Jan 17, 2025Sukhtian Ghiath M.Director, 10% OwnerOption exercise(M)3.5M$2.51$8.7M
Jan 17, 2025GMS Ventures & InvestmentsDirector, 10% OwnerOption exercise(M)3.5M——
Jan 17, 2025GMS Ventures & InvestmentsDirector, 10% OwnerGrant(A)3.5M——
Jan 17, 2025GMS Ventures & InvestmentsDirector, 10% OwnerDisposed to issuer(D)3.5M——
Jan 17, 2025GMS Ventures & InvestmentsDirector, 10% OwnerGrant(A)3.5M——
Jan 17, 2025GMS Ventures & InvestmentsDirector, 10% OwnerGrant(A)3.5M——
Oct 3, 2024Hilzinger Kurt JDirectorGrant(A)19K—$0
Oct 3, 2024Haller Julia ADirectorGrant(A)12K—$0
Oct 3, 2024Huang AndongDirectorGrant(A)11K—$0
Oct 3, 2024Auffarth GerdDirectorGrant(A)12K—$0
Oct 3, 2024Haddadin Yezan MuntherDirectorGrant(A)20K—$0
Oct 3, 2024Sukhtian Faisal GhiathDirectorGrant(A)20K—$0
Oct 1, 2024Sukhtian Faisal GhiathDirectorGrant(A)134K—$0
Oct 1, 2024Hilzinger Kurt JDirectorGrant(A)57K—$0
Oct 1, 2024Hilzinger Kurt JDirectorGrant(A)105K—$0
Oct 1, 2024Thurman Randy HDirectorGrant(A)57K—$0
Oct 1, 2024Thurman Randy HDirectorGrant(A)90K—$0
Oct 1, 2024Gangolli Julian SDirectorGrant(A)71K—$0
Oct 1, 2024Gangolli Julian SDirectorGrant(A)57K—$0
Oct 1, 2024Haller Julia ADirectorGrant(A)57K—$0
Oct 1, 2024Haller Julia ADirectorGrant(A)47K—$0
Oct 1, 2024Huang AndongDirectorGrant(A)24K—$0
Oct 1, 2024Huang AndongDirectorGrant(A)57K—$0
Oct 1, 2024Auffarth GerdDirectorGrant(A)29K—$0
Oct 1, 2024Auffarth GerdDirectorGrant(A)57K—$0
Oct 1, 2024Haddadin Yezan MuntherDirectorGrant(A)57K—$0
Oct 1, 2024Sukhtian Faisal GhiathDirectorGrant(A)57K—$0
Oct 1, 2024Haddadin Yezan MuntherDirectorGrant(A)132K—$0
Sep 26, 2024Kenyon Lawrence AChief Financial Officer, DirectorBuy(P)5K$5.69$28K
Apr 15, 2024Syntone Ventures LLC10% OwnerBuy(P)714K——
Apr 15, 2024Syntone Ventures LLC10% OwnerBuy(P)1.1M——
Mar 28, 2024Haddadin Yezan MuntherDirectorBuy(P)2K$11.82$22K
Mar 20, 2024Kenyon Lawrence ACHIEF FINANCIAL OFFICER, DirectorGrant(A)13K—$0
Mar 20, 2024Trenary C Russell IIICEO AND PRESIDENT, DirectorGrant(A)455K—$0
Mar 20, 2024Evanson JeffCHIEF COMMERCIAL OFFICERGrant(A)25K—$0
Mar 18, 2024Sukhtian Ghiath M.Director, 10% OwnerGrant(A)3.5M——
Mar 18, 2024Sukhtian Ghiath M.Director, 10% OwnerGrant(A)2.3M——
Mar 7, 2024Evanson JeffCHIEF COMMERCIAL OFFICERBuy(P)62K$0.42$26K
Mar 7, 2024Haller Julia ADirectorGrant(A)94K—$0
Mar 7, 2024Huang AndongDirectorGrant(A)94K—$0
Mar 7, 2024Auffarth GerdDirectorGrant(A)94K—$0
Mar 7, 2024Gangolli Julian SDirectorGrant(A)94K—$0
Mar 7, 2024Haddadin Yezan MuntherDirectorGrant(A)94K—$0
Mar 7, 2024Sukhtian Faisal GhiathDirectorGrant(A)94K—$0
Mar 7, 2024Hilzinger Kurt JDirectorGrant(A)94K—$0
Mar 7, 2024Thurman Randy HDirectorGrant(A)94K—$0
Oct 4, 2023Hilzinger Kurt JDirectorGrant(A)287K—$0
Oct 4, 2023Gangolli Julian SDirectorGrant(A)370K—$0
Oct 4, 2023Haddadin Yezan MuntherDirectorGrant(A)358K—$0
Oct 4, 2023Sukhtian Faisal GhiathDirectorGrant(A)373K—$0
Oct 4, 2023Haller Julia ADirectorGrant(A)210K—$0
Oct 4, 2023Huang AndongDirectorGrant(A)191K—$0
Oct 4, 2023Auffarth GerdDirectorGrant(A)210K—$0
Apr 20, 2023Dagnon TerryChief Operations OfficerSell(S)520K$1.14$593K
Apr 17, 2023Dagnon TerryChief Operations OfficerGrant(A)192K—$0
Apr 17, 2023Evanson JeffChief Commercial OfficerGrant(A)192K—$0
Apr 17, 2023Trenary C Russell IIICEO and President, DirectorGrant(A)257K—$0
Mar 29, 2023Haddadin Yezan MuntherDirectorGrant(A)41K—$0
Mar 29, 2023Haller Julia ADirectorGrant(A)41K—$0
Mar 29, 2023Huang AndongDirectorGrant(A)41K—$0

Data Source

Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.

Issuer: Outlook Therapeutics, Inc., SEC CIK 0001649989. The symbol on a Form 4 is typed by the filer, so this page follows the issuer with the newest filing under OTLK and shows every filing by that issuer (also filed as ONS).

Coverage: Form 4 filings indexed 2006-01-02 → 2026-09-15. Earlier history is backfilling; this window widens as it deepens.

Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).

Keep exploring

Connected pages for OTLK